uniQure N.V. SEC filings QURE
uniQure N.V. has 953 filings in SEC EDGAR's recent list, going back to Nov 8, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 29, 2026 | — |
| 424B5 | Prospectus supplement | Jun 24, 2026 | — |
| 424B5 | Prospectus supplement | Jun 22, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2025 | — |
| 424B5 | Prospectus supplement | Sep 24, 2025 | — |
| 424B5 | Prospectus supplement | Jul 29, 2025 | — |
| S-8 | Employee stock plan registration | Jun 30, 2025 | — |
| 424B5 | Prospectus supplement | Jan 8, 2025 | — |
| 424B5 | Prospectus supplement | Jan 7, 2025 | — |
| S-3ASR | Automatic shelf registration | Jan 7, 2025 | — |
| S-8 | Employee stock plan registration | Aug 1, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| S-8 | Employee stock plan registration | Dec 8, 2023 | — |
| S-8 | Employee stock plan registration | Feb 27, 2023 | — |
| S-8 | Employee stock plan registration | Jul 20, 2021 | — |
| 424B5 | Prospectus supplement | Mar 2, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Mar 2, 2020 | — |
| 424B5 | Prospectus supplement | Sep 6, 2019 | — |
| 424B5 | Prospectus supplement | Sep 4, 2019 | — |
| S-3ASR | Automatic shelf registration | Jun 14, 2018 | — |
| S-8 | Employee stock plan registration | Jun 14, 2018 | — |
| 424B5 | Prospectus supplement | May 3, 2018 | — |
| 424B5 | Prospectus supplement | May 1, 2018 | — |
| 424B5 | Prospectus supplement | May 1, 2018 | — |
| S-8 | Employee stock plan registration | Dec 14, 2017 | — |
| 424B5 | Prospectus supplement | Oct 26, 2017 | — |
| 424B5 | Prospectus supplement | Oct 24, 2017 | — |
| 424B5 | Prospectus supplement | Sep 18, 2017 | — |
| S-8 | Employee stock plan registration | May 15, 2017 | — |
| S-3/A | S-3 | May 15, 2017 | — |
| POS AM | Filing | Mar 27, 2017 | — |
| S-3 | Shelf registration | Mar 15, 2017 | — |
| F-3/A | Filing | Mar 15, 2017 | — |
| 424B5 | Prospectus supplement | Apr 13, 2015 | — |
| FWP | Free writing prospectus | Apr 9, 2015 | — |
| FWP | Free writing prospectus | Apr 9, 2015 | — |
| 424B5 | Prospectus supplement | Apr 7, 2015 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 3, 2015 | — |
| S-8 | Employee stock plan registration | Aug 6, 2014 | — |
| 424B4 | Prospectus | Feb 6, 2014 | — |
| FWP | Free writing prospectus | Feb 5, 2014 | — |
| F-1MEF | Filing | Feb 4, 2014 | — |
| F-1/A | Filing | Feb 3, 2014 | — |
| F-1/A | Filing | Jan 31, 2014 | — |
| F-1/A | Filing | Jan 24, 2014 | — |
| F-1/A | Filing | Jan 17, 2014 | — |
| F-1 | Registration statement (foreign issuer) | Jan 2, 2014 | — |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QURE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Amsterdam
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1590560
- Former names
- uniQure B.V. (until Feb 6, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.